RSLS ReShape Lifesciences Price Target

NASDAQ:RSLS   ReShape Lifesciences, Inc
- ReShape leader in weight loss market
- FDA approved Lap-Band manufacturing moved to the US
- eliminated debt overhang
- ReShape Marketplace - digital health solution
June 30, 2021: Cash and cash equivalents and restricted cash were $40.2 million.

ReShape Market Cap only 50.061M
Shares Outstanding 17.20M

On 7/1/2021, Ben Haynor from Alliance Global Partners brokerage Lowered the Price Target from $18.50 to $13.75

My price target is the 9.6usd resistance.
I`m looking forward to read your opinion about RSLS .


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.